155 related articles for article (PubMed ID: 22473497)
1. Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways.
Asavapanumas N; Kittayaruksakul S; Meetam P; Muanprasat C; Chatsudthipong V; Soodvilai S
Drug Metab Pharmacokinet; 2012; 27(5):513-9. PubMed ID: 22473497
[TBL] [Abstract][Full Text] [Related]
2. Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells.
Wongwan T; Kittayaruksakul S; Asavapanumas N; Chatsudthipong V; Soodvilai S
Pflugers Arch; 2017 Nov; 469(11):1471-1481. PubMed ID: 28741179
[TBL] [Abstract][Full Text] [Related]
3. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway.
Huang YC; Liu KC; Chiou YL; Yang CH; Chen TH; Li TT; Liu LL
Chem Biol Interact; 2013 Oct; 205(3):157-64. PubMed ID: 23872139
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse.
Valasek MA; Clarke SL; Repa JJ
J Lipid Res; 2007 Dec; 48(12):2725-35. PubMed ID: 17726195
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
[TBL] [Abstract][Full Text] [Related]
7. Renal organic cation transporters mediated cadmium-induced nephrotoxicity.
Soodvilai S; Nantavishit J; Muanprasat C; Chatsudthipong V
Toxicol Lett; 2011 Jul; 204(1):38-42. PubMed ID: 21513783
[TBL] [Abstract][Full Text] [Related]
8. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
Ann SJ; Chung JH; Park BH; Kim SH; Jang J; Park S; Kang SM; Lee SH
Atherosclerosis; 2015 Jun; 240(2):389-97. PubMed ID: 25881202
[TBL] [Abstract][Full Text] [Related]
9. Role of MAPK and PKA in regulation of rbOCT2-mediated renal organic cation transport.
Soodvilai S; Chatsudthipong A; Chatsudthipong V
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F21-7. PubMed ID: 17327500
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.
Wongwan T; Chatsudthipong V; Soodvilai S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846898
[TBL] [Abstract][Full Text] [Related]
11. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha.
Maeda T; Wakasawa T; Funabashi M; Fukushi A; Fujita M; Motojima K; Tamai I
Biol Pharm Bull; 2008 Jun; 31(6):1230-6. PubMed ID: 18520060
[TBL] [Abstract][Full Text] [Related]
13. Short communication: the pharmacological peroxisome proliferator-activated receptor α agonist WY-14,643 increases expression of novel organic cation transporter 2 and carnitine uptake in bovine kidney cells.
Zhou X; Wen G; Ringseis R; Eder K
J Dairy Sci; 2014; 97(1):345-9. PubMed ID: 24210485
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.
Liu GZ; Hou TT; Yuan Y; Hang PZ; Zhao JJ; Sun L; Zhao GQ; Zhao J; Dong JM; Wang XB; Shi H; Liu YW; Zhou JH; Dong ZX; Liu Y; Zhan CC; Li Y; Li WM
Br J Pharmacol; 2016 Mar; 173(6):1095-109. PubMed ID: 26787506
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
[TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.
Harper JN; Wright SH
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F56-67. PubMed ID: 23034939
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity.
Ramakrishnan SK; Russo L; Ghanem SS; Patel PR; Oyarce AM; Heinrich G; Najjar SM
J Biol Chem; 2016 Nov; 291(46):23915-23924. PubMed ID: 27662905
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
[TBL] [Abstract][Full Text] [Related]
19. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes.
Song IS; Shin HJ; Shin JG
Xenobiotica; 2008 Sep; 38(9):1252-62. PubMed ID: 18728938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
